Quick answer: latest quarter results, by ticker or company name

Rezolute Inc (RZLT)

Healthcare | Biotechnology

Swipe horizontally to view all columns.

Income Statement (Quarterly)	2025-09-30	2025-03-31	2024-12-31	2024-09-30
Revenue	0	0	0	0
Cost of Revenue	0	0	0	0
Gross Profit	0	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	6,788,000	4,740,000	4,453,000	4,187,000
Operating Expenses	19,817,000	20,023,000	17,080,000	16,941,000
Operating Income	-19,817,000	0	-17,080,000	-16,941,000
Interest Expense	0	0	0	0
Income Before Tax	-18,150,000	-18,914,000	-15,730,000	-15,378,000
Income Tax Expense	0	0	0	0
Net Income	-18,150,000	-18,914,000	-15,730,000	-15,378,000
Per Share
EPS	-0.18	-0.27	-0.22	-0.22
EPS Diluted	0.00	0.00	0.00	0.00

Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Revenue	0	0	0	0	0
Cost of Revenue	0	36,000	382,000	256,000	0
Gross Profit	0	-36,000	-382,000	-256,000	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	18,367,000	14,644,000	12,177,000	9,357,000	7,392,000
Operating Expenses	79,894,000	70,423,000	55,990,000	41,612,000	22,379,000
Operating Income	-79,894,000	-70,423,000	-55,990,000	-41,843,000	-22,894,000
Interest Expense	0	0	0	1,807,000	375,000
Income Before Tax	-74,412,000	-68,459,000	-51,787,000	-41,060,000	-20,902,000
Income Tax Expense	0	0	-137,895	-2,279,000	0
Net Income	-74,412,000	-68,459,000	-51,787,000	-38,781,000	-20,902,000
Per Share
EPS	-0.98	-1.33	-1.01	-2.13	-2.72
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Cash and Cash Equivalents	94,107,000	70,396,000	16,036,000	150,410,000
Short Term Investments	73,751,000	56,478,000	85,860,000	0
Net Receivables	0	0	0	0
Inventory	0	0	0	0
Total Current Assets	171,145,000	128,652,999	104,910,000	152,104,000
Property Plant Equipment	1,420,000	1,983,000	2,193,000	168,000
Goodwill and Intangibles	0	0	0	0
Total Assets	175,490,000	132,737,000	123,721,000	152,420,000
Liabilities
Account Payables	5,809,000	4,901,000	3,269,000	1,132,000
Short Term Debt	632,000	568,000	541,000	108,000
Total Current Liabilities	11,912,000	9,606,000	5,200,000	2,462,000
Long Term Debt	983,000	1,660,000	1,937,000	80,000
Total Liabilities	13,363,000	11,734,000	7,549,000	2,949,000
Shareholders Equity
Retained Earnings	-403,856,000	-329,444,000	-260,985,000	-209,198,000
Total Shareholders Equity	162,127,000	121,003,000	116,172,000	149,471,000

Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Assets
Cash and Cash Equivalents	94,107,000	70,396,000	16,036,000	150,410,000	41,047,000
Short Term Investments	73,751,000	56,478,000	85,860,000	0	0
Net Receivables	0	0	0	0	0
Inventory	0	0	0	0	0
Total Current Assets	171,145,000	128,652,999	104,910,000	152,104,000	41,993,000
Property Plant Equipment	1,420,000	1,983,000	2,193,000	168,000	425,000
Goodwill and Intangibles	0	0	0	0	0
Total Assets	175,490,000	132,737,000	123,721,000	152,420,000	42,609,000
Liabilities
Account Payables	5,809,000	4,901,000	3,269,000	1,132,000	1,035,000
Short Term Debt	632,000	568,000	541,000	108,000	265,000
Total Current Liabilities	11,912,000	9,606,000	5,200,000	2,462,000	1,968,000
Long Term Debt	983,000	1,660,000	1,937,000	80,000	14,155,000
Total Liabilities	13,363,000	11,734,000	7,549,000	2,949,000	16,510,000
Shareholders Equity
Retained Earnings	-403,856,000	-329,444,000	-260,985,000	-209,198,000	-168,138,000
Total Shareholders Equity	162,127,000	121,003,000	116,172,000	149,471,000	26,099,000

Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	-74,412,000	-68,459,000	-51,787,000	-41,060,000
Depreciation & Amortization	31,000	36,000	30,000	13,000
Stock Based Compensation	7,121,000	7,360,000	7,268,000	3,685,000
Change in Working Capital	47,000	3,100,000	1,021,000	-642,000
Operating Cash Flow	-69,075,000	-57,368,000	-44,481,000	-39,616,000
Investing Activities
Capital Expenditure	0	0	-153,000	0
Investments	0	0	-153,000	0
Investing Cash Flow	-14,541,000	48,699,000	-101,464,000	0
Financing Activities
Debt Repayment	0	0	0	-16,013,000
Common Stock Issued/Repurchased	107,327,000	49,017,000	12,330,000	112,037,000
Dividends Paid	0	0	0	0
Financing Cash Flow	107,327,000	63,029,000	11,571,000	148,979,000
Summary
Free Cash Flow	-69,075,000	-57,368,000	-44,634,000	-39,616,000
Net Change in Cash	23,711,000	54,360,000	-134,374,000	109,363,000

Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Operating Activities
Net Income	-74,412,000	-68,459,000	-51,787,000	-41,060,000	-20,902,000
Depreciation & Amortization	31,000	36,000	30,000	13,000	13,000
Stock Based Compensation	7,121,000	7,360,000	7,268,000	3,685,000	3,965,000
Change in Working Capital	47,000	3,100,000	1,021,000	-642,000	-2,120,000
Operating Cash Flow	-69,075,000	-57,368,000	-44,481,000	-39,616,000	-20,441,000
Investing Activities
Capital Expenditure	0	0	-153,000	0	0
Investments	0	0	-153,000	0	0
Investing Cash Flow	-14,541,000	48,699,000	-101,464,000	0	0
Financing Activities
Debt Repayment	0	0	0	-16,013,000	0
Common Stock Issued/Repurchased	107,327,000	49,017,000	12,330,000	112,037,000	41,000,000
Dividends Paid	0	0	0	0	0
Financing Cash Flow	107,327,000	63,029,000	11,571,000	148,979,000	51,533,000
Summary
Free Cash Flow	-69,075,000	-57,368,000	-44,634,000	-39,616,000	-20,441,000
Net Change in Cash	23,711,000	54,360,000	-134,374,000	109,363,000	31,092,000